NTRA |
Natera, Inc. |
21.43B |
3.57% |
|
|
|
|
|
162.31 |
-3.50% |
53.42% |
52.65% |
---|
GILD |
Gilead Sciences, Inc. |
137.03B |
2.94% |
|
|
|
|
|
109.95 |
-0.07% |
25.23% |
31.39% |
---|
UTHR |
United Therapeutics Corporation |
16.12B |
2.90% |
|
|
|
|
|
361.10 |
-1.70% |
35.09% |
97.66% |
---|
INCY |
Incyte Corporation |
13.96B |
2.90% |
|
|
|
|
|
72.11 |
1.02% |
42.37% |
83.22% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.03B |
2.88% |
|
|
|
|
|
120.69 |
3.94% |
34.71% |
22.61% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.15B |
2.69% |
|
|
|
|
|
106.28 |
-1.96% |
49.27% |
16.33% |
---|
INSM |
Insmed Incorporated |
14.50B |
2.60% |
|
|
|
|
|
81.06 |
-3.05% |
46.27% |
4.03% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
124.35B |
2.55% |
|
|
|
|
|
484.24 |
0.81% |
29.71% |
30.05% |
---|
EXAS |
Exact Sciences Corporation |
9.12B |
2.45% |
|
|
|
|
|
49.26 |
-0.50% |
63.70% |
17.62% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
32.44B |
2.43% |
|
|
|
|
|
250.59 |
-0.16% |
41.52% |
33.50% |
---|
ABBV |
AbbVie Inc. |
356.74B |
2.34% |
|
|
|
|
|
202.08 |
0.60% |
22.17% |
32.62% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
7.33B |
2.17% |
|
|
|
|
|
336.23 |
-4.22% |
61.15% |
24.27% |
---|
AMGN |
Amgen Inc. |
162.78B |
2.12% |
|
|
|
|
|
303.01 |
1.71% |
21.37% |
8.26% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
13.01B |
2.04% |
|
|
|
|
|
68.25 |
-0.70% |
33.04% |
28.31% |
---|
BIIB |
Biogen Inc. |
20.59B |
2.03% |
|
|
|
|
|
140.64 |
2.59% |
37.81% |
56.88% |
---|
VKTX |
Viking Therapeutics, Inc. |
3.80B |
1.87% |
|
|
|
|
|
34.07 |
7.71% |
105.49% |
45.52% |
---|
TGTX |
TG Therapeutics, Inc. |
4.81B |
1.83% |
|
|
|
|
|
30.88 |
-0.19% |
81.07% |
55.79% |
---|
BPMC |
Blueprint Medicines Corporation |
5.90B |
1.74% |
|
|
|
|
|
92.25 |
-2.23% |
66.68% |
15.72% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
75.29B |
1.66% |
|
|
|
|
|
700.33 |
0.62% |
36.18% |
59.68% |
---|
CYTK |
Cytokinetics, Incorporated |
5.93B |
1.64% |
|
|
|
|
|
50.26 |
-1.68% |
54.27% |
66.40% |
---|
MRNA |
Moderna, Inc. |
13.67B |
1.62% |
|
|
|
|
|
35.53 |
5.34% |
87.43% |
82.80% |
---|
CRSP |
CRISPR Therapeutics AG |
4.11B |
1.48% |
|
|
|
|
|
47.87 |
-5.07% |
61.54% |
46.80% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.11B |
1.39% |
|
|
|
|
|
57.75 |
0.54% |
37.56% |
45.45% |
---|
EXEL |
Exelixis, Inc. |
10.31B |
1.25% |
|
|
|
|
|
36.85 |
5.02% |
35.76% |
27.34% |
---|
ROIV |
Roivant Sciences Ltd. |
7.62B |
1.24% |
|
|
|
|
|
10.68 |
-0.37% |
32.36% |
68.47% |
---|
ALKS |
Alkermes plc |
5.74B |
1.22% |
|
|
|
|
|
35.32 |
-0.51% |
55.46% |
54.71% |
---|
KRYS |
Krystal Biotech, Inc. |
5.40B |
1.20% |
|
|
|
|
|
187.86 |
2.87% |
46.99% |
31.69% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.10B |
1.18% |
|
|
|
|
|
32.32 |
-1.13% |
57.02% |
68.51% |
---|
RVMD |
Revolution Medicines, Inc. |
7.54B |
1.17% |
|
|
|
|
|
41.33 |
-2.20% |
66.81% |
26.62% |
---|
ADMA |
ADMA Biologics, Inc. |
3.74B |
1.16% |
|
|
|
|
|
15.84 |
-1.49% |
61.47% |
19.44% |
---|
APLS |
Apellis Pharmaceuticals, Inc. |
3.42B |
1.07% |
|
|
|
|
|
27.52 |
-2.93% |
43.44% |
38.54% |
---|
BBIO |
BridgeBio Pharma, Inc. |
6.96B |
1.05% |
|
|
|
|
|
36.85 |
0.12% |
60.00% |
23.25% |
---|
TWST |
Twist Bioscience Corporation |
2.46B |
1.05% |
|
|
|
|
|
41.31 |
-8.36% |
66.71% |
12.18% |
---|
RNA |
Avidity Biosciences, Inc. |
3.71B |
1.04% |
|
|
|
|
|
31.12 |
-4.33% |
67.15% |
32.35% |
---|
PCVX |
Vaxcyte, Inc. |
9.94B |
0.90% |
|
|
|
|
|
79.74 |
-3.31% |
62.20% |
46.37% |
---|
BHVN |
Biohaven Pharmaceutical Holding Company ... |
3.73B |
0.89% |
|
|
|
|
|
36.91 |
-7.19% |
62.50% |
22.73% |
---|
GERN |
Geron Corporation |
1.55B |
0.85% |
|
|
|
|
|
2.5700 |
-2.28% |
92.88% |
21.18% |
---|
BEAM |
Beam Therapeutics Inc. |
2.52B |
0.84% |
|
|
|
|
|
30.43 |
-8.18% |
63.92% |
88.15% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
3.47B |
0.83% |
|
|
|
|
|
37.46 |
1.63% |
70.01% |
42.91% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
4.33B |
0.82% |
|
|
|
|
|
58.25 |
-2.80% |
110.33% |
57.59% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
1.76B |
0.80% |
|
|
|
|
|
5.78 |
3.03% |
116.50% |
80.65% |
---|
RXRX |
Recursion Pharmaceuticals, Inc. |
3.56B |
0.78% |
|
|
|
|
|
9.28 |
-10.34% |
110.40% |
46.29% |
---|
SRRK |
Scholar Rock Holding Corporation |
3.53B |
0.77% |
|
|
|
|
|
37.70 |
-3.70% |
62.30% |
11.20% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
3.32B |
0.77% |
|
|
|
|
|
19.95 |
-1.68% |
52.38% |
52.95% |
---|
PTCT |
PTC Therapeutics, Inc. |
3.91B |
0.77% |
|
|
|
|
|
50.69 |
0.62% |
48.14% |
18.88% |
---|
ACLX |
Arcellx, Inc. |
3.45B |
0.73% |
|
|
|
|
|
63.75 |
-2.83% |
46.12% |
25.56% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
3.94B |
0.70% |
|
|
|
|
|
42.59 |
-4.25% |
71.90% |
25.52% |
---|
DYN |
Dyne Therapeutics, Inc. |
1.43B |
0.67% |
|
|
|
|
|
14.01 |
0.14% |
230.48% |
48.24% |
---|
IMVT |
Immunovant, Inc. |
3.61B |
0.66% |
|
|
|
|
|
21.27 |
4.01% |
77.80% |
92.15% |
---|
JANX |
Janux Therapeutics, Inc. |
2.08B |
0.63% |
|
|
|
|
|
36.01 |
-3.12% |
81.13% |
31.24% |
---|
FOLD |
Amicus Therapeutics, Inc. |
2.75B |
0.63% |
|
|
|
|
|
9.19 |
1.32% |
51.71% |
48.01% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.51B |
0.62% |
|
|
|
|
|
19.90 |
-5.06% |
56.04% |
52.45% |
---|
VCYT |
Veracyte, Inc. |
3.04B |
0.61% |
|
|
|
|
|
39.18 |
-4.56% |
62.23% |
50.66% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
2.02B |
0.60% |
|
|
|
|
|
35.22 |
4.36% |
67.83% |
61.09% |
---|
ARQT |
Arcutis Biotherapeutics, Inc. |
1.52B |
0.59% |
|
|
|
|
|
13.02 |
-2.98% |
80.40% |
53.95% |
---|
NUVL |
Nuvalent, Inc. |
5.65B |
0.58% |
|
|
|
|
|
79.49 |
-3.52% |
47.10% |
36.59% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.31B |
0.58% |
|
|
|
|
|
38.75 |
0.68% |
68.70% |
84.70% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
2.52B |
0.57% |
|
|
|
|
|
52.45 |
-1.34% |
49.91% |
47.78% |
---|
RYTM |
Rhythm Pharmaceuticals, Inc. |
3.45B |
0.56% |
|
|
|
|
|
56.07 |
-2.89% |
54.39% |
34.17% |
---|
NVAX |
Novavax, Inc. |
1.28B |
0.54% |
|
|
|
|
|
7.99 |
0.88% |
110.93% |
53.06% |
---|
VERA |
Vera Therapeutics, Inc. |
1.81B |
0.54% |
|
|
|
|
|
28.58 |
-3.48% |
65.71% |
41.74% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.24B |
0.53% |
|
|
|
|
|
12.17 |
-0.65% |
84.48% |
67.28% |
---|
DVAX |
Dynavax Technologies Corporation |
1.75B |
0.53% |
|
|
|
|
|
13.33 |
0.00% |
247.79% |
42.08% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
1.91B |
0.51% |
|
|
|
|
|
21.85 |
0.55% |
142.62% |
50.52% |
---|
ARDX |
Ardelyx, Inc. |
1.20B |
0.50% |
|
|
|
|
|
5.06 |
-11.54% |
88.22% |
35.01% |
---|
VCEL |
Vericel Corporation |
2.57B |
0.47% |
|
|
|
|
|
52.00 |
-4.25% |
58.27% |
68.59% |
---|
KYMR |
Kymera Therapeutics, Inc. |
2.38B |
0.44% |
|
|
|
|
|
36.81 |
-1.63% |
67.60% |
98.16% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.91B |
0.43% |
|
|
|
|
|
9.21 |
-1.92% |
50.70% |
31.73% |
---|
DNLI |
Denali Therapeutics Inc. |
2.98B |
0.43% |
|
|
|
|
|
20.73 |
-3.98% |
64.25% |
67.19% |
---|
SLNO |
Soleno Therapeutics, Inc. |
1.99B |
0.42% |
|
|
|
|
|
46.13 |
-2.72% |
69.57% |
73.97% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
2.58B |
0.41% |
|
|
|
|
|
21.62 |
-1.95% |
42.34% |
61.47% |
---|
AKRO |
Akero Therapeutics, Inc. |
3.89B |
0.41% |
|
|
|
|
|
51.84 |
2.49% |
73.43% |
9.65% |
---|
APGE |
Apogee Therapeutics, Inc. |
2.02B |
0.40% |
|
|
|
|
|
34.55 |
1.77% |
66.75% |
58.62% |
---|
PRAX |
Praxis Precision Medicines, Inc. |
1.39B |
0.40% |
|
|
|
|
|
74.49 |
-6.35% |
167.62% |
93.03% |
---|
IRON |
Disc Medicine, Inc. |
1.87B |
0.38% |
|
|
|
|
|
54.53 |
0.33% |
76.09% |
3.77% |
---|
CLDX |
Celldex Therapeutics, Inc. |
1.49B |
0.37% |
|
|
|
|
|
22.46 |
-0.58% |
48.11% |
8.05% |
---|
SNDX |
Syndax Pharmaceuticals, Inc. |
1.40B |
0.37% |
|
|
|
|
|
16.38 |
2.44% |
77.62% |
45.74% |
---|
CGON |
CG Oncology, Inc. Common stock |
2.12B |
0.36% |
|
|
|
|
|
27.85 |
-1.31% |
102.73% |
25.34% |
---|
SMMT |
Summit Therapeutics Inc. |
16.30B |
0.32% |
|
|
|
|
|
22.12 |
-4.08% |
89.17% |
21.99% |
---|
MNKD |
MannKind Corporation |
1.59B |
0.31% |
|
|
|
|
|
5.76 |
1.77% |
97.36% |
67.13% |
---|
VRDN |
Viridian Therapeutics, Inc. |
1.29B |
0.31% |
|
|
|
|
|
16.27 |
-2.11% |
48.83% |
22.20% |
---|
NRIX |
Nurix Therapeutics, Inc. |
1.28B |
0.30% |
|
|
|
|
|
16.87 |
-1.00% |
80.19% |
29.92% |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
1.25B |
0.27% |
|
|
|
|
|
12.43 |
1.64% |
62.90% |
22.19% |
---|
SYRE |
Spyre Therapeutics, Inc. |
1.25B |
0.27% |
|
|
|
|
|
21.29 |
-5.00% |
139.55% |
20.80% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.91B |
0.25% |
|
|
|
|
|
21.98 |
-6.79% |
77.53% |
13.95% |
---|
XNCR |
Xencor, Inc. |
1.10B |
0.25% |
|
|
|
|
|
15.74 |
-0.32% |
81.40% |
45.37% |
---|
CDNA |
CareDx, Inc |
1.20B |
0.24% |
|
|
|
|
|
22.29 |
-4.66% |
110.71% |
37.13% |
---|
MYGN |
Myriad Genetics, Inc. |
1.29B |
0.24% |
|
|
|
|
|
14.18 |
-5.34% |
60.35% |
59.69% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
1.11B |
0.24% |
|
|
|
|
|
10.47 |
-3.68% |
217.96% |
49.65% |
---|
CDMO |
Avid Bioservices, Inc. |
798.90M |
0.22% |
|
|
|
|
|
12.49 |
0.00% |
240.18% |
N/A |
---|
ALT |
Altimmune, Inc. |
457.33M |
0.22% |
|
|
|
|
|
6.43 |
-3.02% |
89.20% |
43.08% |
---|
IBRX |
ImmunityBio, Inc. |
2.50B |
0.22% |
|
|
|
|
|
3.42 |
-6.04% |
162.94% |
29.33% |
---|
RCUS |
Arcus Biosciences, Inc. |
1.16B |
0.22% |
|
|
|
|
|
11.07 |
3.07% |
286.49% |
36.95% |
---|
IRWD |
Ironwood Pharmaceuticals, Inc. |
290.45M |
0.21% |
|
|
|
|
|
1.8150 |
-4.47% |
191.36% |
37.44% |
---|
CGEM |
Cullinan Oncology, Inc. |
525.80M |
0.21% |
|
|
|
|
|
9.03 |
-1.31% |
173.08% |
45.93% |
---|
VIR |
Vir Biotechnology, Inc. |
1.32B |
0.21% |
|
|
|
|
|
9.57 |
-2.35% |
70.90% |
60.24% |
---|
AVXL |
Anavex Life Sciences Corp. |
710.29M |
0.20% |
|
|
|
|
|
8.35 |
-3.80% |
98.87% |
24.74% |
---|
EBS |
Emergent BioSolutions Inc. |
417.76M |
0.20% |
|
|
|
|
|
7.71 |
-1.66% |
186.20% |
26.57% |
---|
REPL |
Replimune Group, Inc. |
1.08B |
0.20% |
|
|
|
|
|
13.98 |
-2.31% |
122.01% |
11.97% |
---|
VERV |
Verve Therapeutics, Inc. |
616.35M |
0.18% |
|
|
|
|
|
7.28 |
-7.02% |
154.23% |
39.24% |
---|